Trial intelligence / Profile preview

Metreleptin for Weight Loss After Gastric Bypass

NCT00710814Phase 2Completed

Sponsor
Columbia University
Start
Apr 2008
Primary completion
Aug 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of metreleptin in obesity, sponsored by Columbia University. Started Apr 2008; status: completed.

02

Drugs

metreleptin
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00710814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00710814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call